5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(2-piperidin-1-ylethoxy)phenyl]-1H-indazole;5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole;5-[5-(cyclopropylmethyl)-1H-1,2,4-triazol-3-yl]-3-(2,2-difluoro-1,3-benzodioxol-5-yl)-1H-indazole;3-(3-fluoro-4-methoxyphenyl)-1H-indazole-5-carboxamide;5-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole

C115H127F3N26O7 — CID 158096335

IUPAC5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(2-piperidin-1-ylethoxy)phenyl]-1H-indazole;5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole;5-[5-(cyclopropylmethyl)-1H-1,2,4-triazol-3-yl]-3-(2,2-difluoro-1,3-benzodioxol-5-yl)-1H-indazole;3-(3-fluoro-4-methoxyphenyl)-1H-indazole-5-carboxamide;5-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole
SMILESCC(C)(C)c1nc(-c2ccc3[nH]nc(-c4cccc(OCCCN5CCCCC5)c4)c3c2)n[nH]1.CC(C)(C)c1nc(-c2ccc3[nH]nc(-c4cccc(OCCN5CCCCC5)c4)c3c2)n[nH]1.CC(C)Cc1nc(-c2ccc3[nH]nc(-c4cccc(OCCCN5CCCCC5)c4)c3c2)n[nH]1.COc1ccc(-c2n[nH]c3ccc(C(N)=O)cc23)cc1F.FC1(F)Oc2ccc(-c3n[nH]c4ccc(-c5n[nH]c(CC6CC6)n5)cc34)cc2O1
InChIInChI=1S/2C27H34N6O.C26H32N6O.C20H15F2N5O2.C15H12FN3O2/c1-27(2,3)26-28-25(31-32-26)20-11-12-23-22(18-20)24(30-29-23)19-9-7-10-21(17-19)34-16-8-15-33-13-5-4-6-14-33;1-19(2)16-25-28-27(32-30-25)21-10-11-24-23(18-21)26(31-29-24)20-8-6-9-22(17-20)34-15-7-14-33-12-4-3-5-13-33;1-26(2,3)25-27-24(30-31-25)19-10-11-22-21(17-19)23(29-28-22)18-8-7-9-20(16-18)33-15-14-32-12-5-4-6-13-32;21-20(22)28-15-6-4-11(9-16(15)29-20)18-13-8-12(3-5-14(13)24-26-18)19-23-17(25-27-19)7-10-1-2-10;1-21-13-5-3-8(7-11(13)16)14-10-6-9(15(17)20)2-4-12(10)18-19-14/h7,9-12,17-18H,4-6,8,13-16H2,1-3H3,(H,29,30)(H,28,31,32);6,8-11,17-19H,3-5,7,12-16H2,1-2H3,(H,29,31)(H,28,30,32);7-11,16-17H,4-6,12-15H2,1-3H3,(H,28,29)(H,27,30,31);3-6,8-10H,1-2,7H2,(H,24,26)(H,23,25,27);2-7H,1H3,(H2,17,20)(H,18,19)
InChIKeyFOSFSNPDEBGSHY-UHFFFAOYSA-N
MW2042.45 g/mol
LogP22.98
Rot. Bonds29

About 5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(2-piperidin-1-ylethoxy)phenyl]-1H-indazole;5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole;5-[5-(cyclopropylmethyl)-1H-1,2,4-triazol-3-yl]-3-(2,2-difluoro-1,3-benzodioxol-5-yl)-1H-indazole;3-(3-fluoro-4-methoxyphenyl)-1H-indazole-5-carboxamide;5-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole

5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(2-piperidin-1-ylethoxy)phenyl]-1H-indazole;5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole;5-[5-(cyclopropylmethyl)-1H-1,2,4-triazol-3-yl]-3-(2,2-difluoro-1,3-benzodioxol-5-yl)-1H-indazole;3-(3-fluoro-4-methoxyphenyl)-1H-indazole-5-carboxamide;5-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole (PubChem CID 158096335) has the molecular formula C115H127F3N26O7 and a molecular weight of 2042.45 g/mol. Its IUPAC name is 5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(2-piperidin-1-ylethoxy)phenyl]-1H-indazole;5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole;5-[5-(cyclopropylmethyl)-1H-1,2,4-triazol-3-yl]-3-(2,2-difluoro-1,3-benzodioxol-5-yl)-1H-indazole;3-(3-fluoro-4-methoxyphenyl)-1H-indazole-5-carboxamide;5-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole.

Molecular Properties

Compound Name5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(2-piperidin-1-ylethoxy)phenyl]-1H-indazole;5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole;5-[5-(cyclopropylmethyl)-1H-1,2,4-triazol-3-yl]-3-(2,2-difluoro-1,3-benzodioxol-5-yl)-1H-indazole;3-(3-fluoro-4-methoxyphenyl)-1H-indazole-5-carboxamide;5-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole
PubChem CID158096335
Molecular FormulaC115H127F3N26O7
Molecular Weight2042.45 g/mol
Exact Mass2041.03
IUPAC Name5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(2-piperidin-1-ylethoxy)phenyl]-1H-indazole;5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole;5-[5-(cyclopropylmethyl)-1H-1,2,4-triazol-3-yl]-3-(2,2-difluoro-1,3-benzodioxol-5-yl)-1H-indazole;3-(3-fluoro-4-methoxyphenyl)-1H-indazole-5-carboxamide;5-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole
SMILESCC(C)(C)c1nc(-c2ccc3[nH]nc(-c4cccc(OCCCN5CCCCC5)c4)c3c2)n[nH]1.CC(C)(C)c1nc(-c2ccc3[nH]nc(-c4cccc(OCCN5CCCCC5)c4)c3c2)n[nH]1.CC(C)Cc1nc(-c2ccc3[nH]nc(-c4cccc(OCCCN5CCCCC5)c4)c3c2)n[nH]1.COc1ccc(-c2n[nH]c3ccc(C(N)=O)cc23)cc1F.FC1(F)Oc2ccc(-c3n[nH]c4ccc(-c5n[nH]c(CC6CC6)n5)cc34)cc2O1
InChIInChI=1S/2C27H34N6O.C26H32N6O.C20H15F2N5O2.C15H12FN3O2/c1-27(2,3)26-28-25(31-32-26)20-11-12-23-22(18-20)24(30-29-23)19-9-7-10-21(17-19)34-16-8-15-33-13-5-4-6-14-33;1-19(2)16-25-28-27(32-30-25)21-10-11-24-23(18-21)26(31-29-24)20-8-6-9-22(17-20)34-15-7-14-33-12-4-3-5-13-33;1-26(2,3)25-27-24(30-31-25)19-10-11-22-21(17-19)23(29-28-22)18-8-7-9-20(16-18)33-15-14-32-12-5-4-6-13-32;21-20(22)28-15-6-4-11(9-16(15)29-20)18-13-8-12(3-5-14(13)24-26-18)19-23-17(25-27-19)7-10-1-2-10;1-21-13-5-3-8(7-11(13)16)14-10-6-9(15(17)20)2-4-12(10)18-19-14/h7,9-12,17-18H,4-6,8,13-16H2,1-3H3,(H,29,30)(H,28,31,32);6,8-11,17-19H,3-5,7,12-16H2,1-2H3,(H,29,31)(H,28,30,32);7-11,16-17H,4-6,12-15H2,1-3H3,(H,28,29)(H,27,30,31);3-6,8-10H,1-2,7H2,(H,24,26)(H,23,25,27);2-7H,1H3,(H2,17,20)(H,18,19)
InChIKeyFOSFSNPDEBGSHY-UHFFFAOYSA-N
XLogP22.98
TPSA417.87 Ų
H-Bond Donors10
H-Bond Acceptors23
Rotatable Bonds29
Heavy Atoms151
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002042.45
LogP ≤ 522.98
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(2-piperidin-1-ylethoxy)phenyl]-1H-indazole;5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole;5-[5-(cyclopropylmethyl)-1H-1,2,4-triazol-3-yl]-3-(2,2-difluoro-1,3-benzodioxol-5-yl)-1H-indazole;3-(3-fluoro-4-methoxyphenyl)-1H-indazole-5-carboxamide;5-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(2-piperidin-1-ylethoxy)phenyl]-1H-indazole;5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole;5-[5-(cyclopropylmethyl)-1H-1,2,4-triazol-3-yl]-3-(2,2-difluoro-1,3-benzodioxol-5-yl)-1H-indazole;3-(3-fluoro-4-methoxyphenyl)-1H-indazole-5-carboxamide;5-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole?
The IUPAC name of 5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(2-piperidin-1-ylethoxy)phenyl]-1H-indazole;5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole;5-[5-(cyclopropylmethyl)-1H-1,2,4-triazol-3-yl]-3-(2,2-difluoro-1,3-benzodioxol-5-yl)-1H-indazole;3-(3-fluoro-4-methoxyphenyl)-1H-indazole-5-carboxamide;5-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole (CID 158096335) is 5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(2-piperidin-1-ylethoxy)phenyl]-1H-indazole;5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole;5-[5-(cyclopropylmethyl)-1H-1,2,4-triazol-3-yl]-3-(2,2-difluoro-1,3-benzodioxol-5-yl)-1H-indazole;3-(3-fluoro-4-methoxyphenyl)-1H-indazole-5-carboxamide;5-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole.
What is the SMILES notation for 5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(2-piperidin-1-ylethoxy)phenyl]-1H-indazole;5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole;5-[5-(cyclopropylmethyl)-1H-1,2,4-triazol-3-yl]-3-(2,2-difluoro-1,3-benzodioxol-5-yl)-1H-indazole;3-(3-fluoro-4-methoxyphenyl)-1H-indazole-5-carboxamide;5-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole?
The canonical SMILES for 5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(2-piperidin-1-ylethoxy)phenyl]-1H-indazole;5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole;5-[5-(cyclopropylmethyl)-1H-1,2,4-triazol-3-yl]-3-(2,2-difluoro-1,3-benzodioxol-5-yl)-1H-indazole;3-(3-fluoro-4-methoxyphenyl)-1H-indazole-5-carboxamide;5-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole is CC(C)(C)c1nc(-c2ccc3[nH]nc(-c4cccc(OCCCN5CCCCC5)c4)c3c2)n[nH]1.CC(C)(C)c1nc(-c2ccc3[nH]nc(-c4cccc(OCCN5CCCCC5)c4)c3c2)n[nH]1.CC(C)Cc1nc(-c2ccc3[nH]nc(-c4cccc(OCCCN5CCCCC5)c4)c3c2)n[nH]1.COc1ccc(-c2n[nH]c3ccc(C(N)=O)cc23)cc1F.FC1(F)Oc2ccc(-c3n[nH]c4ccc(-c5n[nH]c(CC6CC6)n5)cc34)cc2O1.
What is the InChIKey of 5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(2-piperidin-1-ylethoxy)phenyl]-1H-indazole;5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole;5-[5-(cyclopropylmethyl)-1H-1,2,4-triazol-3-yl]-3-(2,2-difluoro-1,3-benzodioxol-5-yl)-1H-indazole;3-(3-fluoro-4-methoxyphenyl)-1H-indazole-5-carboxamide;5-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole?
The InChIKey is FOSFSNPDEBGSHY-UHFFFAOYSA-N. The full InChI is InChI=1S/2C27H34N6O.C26H32N6O.C20H15F2N5O2.C15H12FN3O2/c1-27(2,3)26-28-25(31-32-26)20-11-12-23-22(18-20)24(30-29-23)19-9-7-10-21(17-19)34-16-8-15-33-13-5-4-6-14-33;1-19(2)16-25-28-27(32-30-25)21-10-11-24-23(18-21)26(31-29-24)20-8-6-9-22(17-20)34-15-7-14-33-12-4-3-5-13-33;1-26(2,3)25-27-24(30-31-25)19-10-11-22-21(17-19)23(29-28-22)18-8-7-9-20(16-18)33-15-14-32-12-5-4-6-13-32;21-20(22)28-15-6-4-11(9-16(15)29-20)18-13-8-12(3-5-14(13)24-26-18)19-23-17(25-27-19)7-10-1-2-10;1-21-13-5-3-8(7-11(13)16)14-10-6-9(15(17)20)2-4-12(10)18-19-14/h7,9-12,17-18H,4-6,8,13-16H2,1-3H3,(H,29,30)(H,28,31,32);6,8-11,17-19H,3-5,7,12-16H2,1-2H3,(H,29,31)(H,28,30,32);7-11,16-17H,4-6,12-15H2,1-3H3,(H,28,29)(H,27,30,31);3-6,8-10H,1-2,7H2,(H,24,26)(H,23,25,27);2-7H,1H3,(H2,17,20)(H,18,19).
What are the key properties of 5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(2-piperidin-1-ylethoxy)phenyl]-1H-indazole;5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole;5-[5-(cyclopropylmethyl)-1H-1,2,4-triazol-3-yl]-3-(2,2-difluoro-1,3-benzodioxol-5-yl)-1H-indazole;3-(3-fluoro-4-methoxyphenyl)-1H-indazole-5-carboxamide;5-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole?
5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(2-piperidin-1-ylethoxy)phenyl]-1H-indazole;5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole;5-[5-(cyclopropylmethyl)-1H-1,2,4-triazol-3-yl]-3-(2,2-difluoro-1,3-benzodioxol-5-yl)-1H-indazole;3-(3-fluoro-4-methoxyphenyl)-1H-indazole-5-carboxamide;5-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole has a molecular weight of 2042.45 g/mol, XLogP of 22.98, 29 rotatable bonds, 10 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for 5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(2-piperidin-1-ylethoxy)phenyl]-1H-indazole;5-(5-tert-butyl-1H-1,2,4-triazol-3-yl)-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole;5-[5-(cyclopropylmethyl)-1H-1,2,4-triazol-3-yl]-3-(2,2-difluoro-1,3-benzodioxol-5-yl)-1H-indazole;3-(3-fluoro-4-methoxyphenyl)-1H-indazole-5-carboxamide;5-[5-(2-methylpropyl)-1H-1,2,4-triazol-3-yl]-3-[3-(3-piperidin-1-ylpropoxy)phenyl]-1H-indazole is sourced from PubChem (CID 158096335), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).